Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III

Clinical trial NCT05141305 · COMPLETED

Trial details

NCT number: NCT05141305
Sponsor: Beijing Tiantan Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ischemic Stroke, Acute

Start date: 2022-01-19
Primary completion: 2024-01-29
Enrollment: 516

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.